Skip to main content
Clinical Trials/NCT02407535
NCT02407535
Completed
Not Applicable

Assessing the Ultrasound Done on a the Uterus After Hysterectomy as a Diagnostic Tool for the Depth of Endometrial Carcinoma Invasion Into the Myometrium

Carmel Medical Center1 site in 1 country20 target enrollmentMarch 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Endometrial Endometroid Carcinoma
Sponsor
Carmel Medical Center
Enrollment
20
Locations
1
Primary Endpoint
Tumor invasion
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

In this study the investigators aim to assess the diagnostic performance of intraoperative, ultrasonographic assessment of the surgical extracted uterus for determining myometrial invasion's depth in comparison to preoperative ultrasound, intraoperative gross inspection and final pathological report (gold standard). The investigators hope that intraoperative gross inspection of the extracted uterus might offer an additional intraoperative tool for assessing the need for pelvic lymphadenectomy in early stage of endometrial cancer at least as good as pathological exam.

Registry
clinicaltrials.gov
Start Date
March 2015
End Date
June 1, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Sponsor
Carmel Medical Center
Responsible Party
Principal Investigator
Principal Investigator

Ido Feferkorn

MD

Carmel Medical Center

Eligibility Criteria

Inclusion Criteria

  • Patient's age is 18 or above
  • Patient has been scheduled to undergo hysterectomy (laparoscopic or abdominal) for the staging and treatment of endometrial cancer (endometrioid subtype) and with the relevant suspected symptoms.
  • Patient able to understand,read and sign informed consent.
  • Patient is not participating in other medical trials at present or in the past 30 days

Exclusion Criteria

  • Age under 18 years
  • Patients assessed preoperatively to be at stage 2 and higher endometrial carcinoma
  • Subjects which their biopsy in the pre operating process will include high risk cell types:
  • Grade 3 endometrioid adenocarcinoma,
  • clear cell carcinoma
  • papillary serous carcinoma
  • carcinosarcoma

Outcomes

Primary Outcomes

Tumor invasion

Time Frame: Average of 2 weeks (immediate assessment by ultrasound, average of 2 weeks for final pathological report)

Tumor invasion (in millimeters and in percentage of myometrial size) as assessed by ultrasound in comparison to macroscopic assesment during surgery and to final pathological report)

Study Sites (1)

Loading locations...

Similar Trials